Perindopril: A Review of its Use in Patients With or at Risk of Developing Coronary Artery Disease

Author： Curran Monique P. McCormack Paul L. Simpson Dene

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.2, 2006-01, pp. : 235-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 211-230

Adis International

Access to resources Recommend Favorite

Perindopril is beneficial among patients with stable coronary artery disease who are receiving calcium channel blockers

Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Perindopril: An Updated Review of Its Use in Hypertension

By Hurst M. Jarvis B.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 867-896

Adis International

Access to resources Recommend Favorite

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

By Brugts J. Maat M. Boersma E. Witteman J. Duijn C. Uitterlinden A. Bertrand M. Remme W. Fox K. Ferrari R. Danser A. Simoons M.

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 171-181

Springer Publishing Company

Access to resources Recommend Favorite

Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia

By Mehta Anita Shah Urmil Parikh Keyur Chag Milan Baxi Hemang Chandarana Anish Naik Ajay Naik Asha Shah Kanan Goyal Ramesh

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 6, 2007-06 ,pp. : 628-633

NRC Research Press

Access to resources Recommend Favorite